These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30862377)

  • 1. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Buszewicz M;
    Lancet; 2019 Apr; 393(10180):1505-1516. PubMed ID: 30862377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Adeleke M; Vickerstaff V; Ambler G; Hunter R; Bunce C; Nathwani N; Barton K;
    Ophthalmology; 2023 Feb; 130(2):139-151. PubMed ID: 36122660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial.
    Vickerstaff V; Ambler G; Bunce C; Xing W; Gazzard G;
    Trials; 2015 Nov; 16():517. PubMed ID: 26559142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
    Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
    Trials; 2015 Sep; 16():406. PubMed ID: 26362541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Barton K; Wormald R; Morris S; Hunter R; Rubin G; Buszewicz M; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):593-598. PubMed ID: 28903966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension.
    Rolim-de-Moura CR; Paranhos A; Loutfi M; Burton D; Wormald R; Evans JR
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD003919. PubMed ID: 35943114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial.
    Philippin H; Matayan E; Knoll KM; Macha E; Mbishi S; Makupa A; Matsinhe C; da Gama V; Monjane M; Ncheda AJ; Mulobuana FA; Muna E; Fopoussi N; Gazzard G; Marques AP; Shah P; Macleod D; Makupa WU; Burton MJ
    Lancet Glob Health; 2021 Nov; 9(11):e1589-e1599. PubMed ID: 34655547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics.
    Konstantakopoulou E; Gazzard G; Vickerstaff V; Jiang Y; Nathwani N; Hunter R; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):599-603. PubMed ID: 28982956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma.
    McIlraith I; Strasfeld M; Colev G; Hutnik CM
    J Glaucoma; 2006 Apr; 15(2):124-30. PubMed ID: 16633226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
    Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
    Ophthalmology; 2019 Sep; 126(9):1238-1248. PubMed ID: 31028768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Laser Trabeculoplasty as a Substitute for Medications in Patients with Mild-to-moderate Glaucoma in the Brazilian Public Health System.
    Barbosa LEO; Barboza WL; Guedes RP; Pereira CDR; Susanna R; Hatanaka M
    J Glaucoma; 2024 May; 33(5):303-309. PubMed ID: 38129951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients.
    Shi Y; Zhang Y; Sun W; Huang AS; Chen S; Zhang L; Wang W; Xie L; Xie X
    Sci Rep; 2023 Jul; 13(1):12179. PubMed ID: 37500642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the efficacy of selective laser trabeculoplasty as initial or adjunctive treatment for primary open-angle glaucoma.
    Gračner T
    Eur J Ophthalmol; 2019 Sep; 29(5):524-531. PubMed ID: 30229662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.
    Woo DM; Healey PR; Graham SL; Goldberg I
    Clin Exp Ophthalmol; 2015; 43(4):320-7. PubMed ID: 25287743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial.
    Katz LJ; Steinmann WC; Kabir A; Molineaux J; Wizov SS; Marcellino G;
    J Glaucoma; 2012 Sep; 21(7):460-8. PubMed ID: 21543992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser trabeculoplasty for open angle glaucoma.
    Rolim de Moura C; Paranhos A; Wormald R
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003919. PubMed ID: 17943806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation.
    Kent SS; Hutnik CM; Birt CM; Damji KF; Harasymowycz P; Si F; Hodge W; Pan I; Crichton A
    J Glaucoma; 2015; 24(5):344-7. PubMed ID: 23835670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial.
    Ang GS; Fenwick EK; Constantinou M; Gan ATL; Man REK; Casson RJ; Finkelstein EA; Goldberg I; Healey PR; Pesudovs K; Sanmugasundram S; Xie J; McIntosh R; Jackson J; Wells AP; White A; Martin K; Walland MJ; Crowston JG; Lamoureux EL
    Br J Ophthalmol; 2020 Jun; 104(6):813-821. PubMed ID: 31488427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.